Summary
A five-year follow-up study on GLP-1 drugs reveals sustained health benefits.
Balanced Perspective
Positive results, but questions remain about lifelong dependence and cost.
Optimistic View
Finally, an evidence-based long-term solution for the obesity epidemic.
Critical View
We are medicalizing weight instead of addressing unhealthy food systems.
Source
Originally reported by NEJM